29,781 Align Technology, Inc. $ALGN Shares Acquired by Signaturefd LLC

Signaturefd LLC raised its position in Align Technology, Inc. (NASDAQ:ALGN) by 2,399.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,022 shares of the medical equipment provider’s stock after buying an additional 29,781 shares during the period. Signaturefd LLC’s holdings in Align Technology were worth $4,132,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Gibbs Wealth Management grew its holdings in shares of Align Technology by 4.2% in the third quarter. Gibbs Wealth Management now owns 4,532 shares of the medical equipment provider’s stock valued at $632,000 after acquiring an additional 181 shares in the last quarter. Manchester Capital Management LLC lifted its holdings in Align Technology by 12,957.1% during the third quarter. Manchester Capital Management LLC now owns 9,140 shares of the medical equipment provider’s stock worth $1,210,000 after acquiring an additional 9,070 shares during the period. Farmers & Merchants Investments Inc. lifted its holdings in Align Technology by 172,320.8% during the third quarter. Farmers & Merchants Investments Inc. now owns 82,762 shares of the medical equipment provider’s stock worth $10,951,000 after acquiring an additional 82,714 shares during the period. Sterling Capital Management LLC lifted its holdings in Align Technology by 4,594.7% during the third quarter. Sterling Capital Management LLC now owns 202,764 shares of the medical equipment provider’s stock worth $26,883,000 after acquiring an additional 198,445 shares during the period. Finally, Yousif Capital Management LLC boosted its position in Align Technology by 1,356.9% in the third quarter. Yousif Capital Management LLC now owns 132,445 shares of the medical equipment provider’s stock worth $17,648,000 after purchasing an additional 123,354 shares during the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $154.51 on Monday. Align Technology, Inc. has a one year low of $130.23 and a one year high of $200.43. The business’s fifty day moving average price is $151.62 and its 200-day moving average price is $166.51. The stock has a market capitalization of $11.07 billion, a PE ratio of 26.87, a P/E/G ratio of 1.66 and a beta of 1.67.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, topping the consensus estimate of $2.62 by $0.02. Align Technology had a return on equity of 15.86% and a net margin of 9.99%. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the company earned $2.49 EPS. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. As a group, equities analysts expect that Align Technology, Inc. will post 9.27 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Evercore downgraded Align Technology from an “outperform” rating to an “in-line” rating and set a $155.00 price objective for the company. in a research note on Monday, October 5th. Zacks Research lowered Align Technology from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Needham & Company LLC reiterated a “hold” rating on shares of Align Technology in a research note on Thursday, July 30th. Weiss Ratings upgraded Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Finally, Stifel Nicolaus cut their price target on shares of Align Technology from $210.00 to $175.00 and set a “buy” rating on the stock in a report on Friday, October 9th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $190.93.

Align Technology Profile

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align’s products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.